DOTATOC PET/CT for Imaging NET Patients

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2028

Conditions
Neuroendocrine TumorsInsulinomaGastrinomaGlucagonomaVipomaPheochromocytomaParagangliomaNeuroblastomaGanglioneuromaMedullary CarcinomaPituitary AdenomaMedulloblastomaMerkel Cell CarcinomaSmall-cell Lung CancerMeningiomaCarcinoid
Interventions
DIAGNOSTIC_TEST

68Ga-DOTATOC PET/CT

"Blood pressure, heart rate, and oxygen saturation levels will be recorded prior to the injection and at 5 - 15 minutes after injection.~Each study subject will have an intravenous catheter inserted. The subject will receive a bolus intravenous dose of the radiotracer from an approved study supplier site.~The subject will rest in a comfortable chair for 60 minutes. After this uptake phase, the blood pressure, heart rate, and oxygen saturation levels will be recorded again. The subjects will then be taken to a designated washroom and asked to void prior to being scanned in order to clear excreted radiotracer activity from the urinary tract.~Subjects are positioned supine, arms down, and centered on the scanner bed and the PET/CT images will be acquired."

DIAGNOSTIC_TEST

18F-FDG PET/CT

"18F-FDG PET/CT For 18F-FDG as fasting period of 6 hours is required before the scan.~Each study subject will have an intravenous catheter inserted. The subject will receive a bolus intravenous dose of the radiotracer from an approved study supplier site.~The subject will rest in a comfortable chair for 60 minutes. The subjects will then be taken to a designated washroom and asked to void prior to being scanned in order to clear excreted radiotracer activity from the urinary tract.~Subjects are positioned supine, arms down, and centered on the scanner bed and the PET/CT images will be acquired."

Trial Locations (1)

V5Z 4E6

BC Cancer, Vancouver

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT03583528 - DOTATOC PET/CT for Imaging NET Patients | Biotech Hunter | Biotech Hunter